Ontology highlight
ABSTRACT: Background
Resection of colorectal liver metastases (CLM) can cure disease, but many patients with extensive disease cannot be fully resected and others recur following surgery. Hepatic arterial infusion (HAI) chemotherapy can convert extensive liver disease to a resectable state or decrease recurrence risk, but response varies and no biomarkers currently exist to identify patients most likely to benefit.Methods
We performed a retrospective cohort study of CLM patients receiving HAI chemotherapy whose tumors underwent MSK-IMPACT sequencing. The frequency of oncogenic alterations and their association with overall survival (OS) and objective response rate were analyzed at the individual gene and signaling pathway levels.Results
Three hundred and seventy patients met
SUBMITTER: Smith JJ
PROVIDER: S-EPMC6825986 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature